← Back
Data updated: Mar 10, 2026
AREVA PHARMS
Infectious DiseaseRespiratory
AREVA PHARMS is a generic drug manufacturer focused on Infectious Disease, Respiratory. Key products include CASPOFUNGIN ACETATE.
2008
Since
5
Drugs
-
Trials
20
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FUROSEMIDE 2026-01-08
FUROSEMIDE 2025-09-12
Labeling
FUROSEMIDE 2025-09-08
Labeling
FUROSEMIDE 2025-08-06
Labeling
CASPOFUNGIN ACETATE 2025-07-18
FUROSEMIDE 2025-07-17
FLUDARABINE PHOSPHATE 2025-07-01
Labeling
PAMIDRONATE DISODIUM 2025-05-22
Labeling
FUROSEMIDE 2025-05-08
Labeling
CASPOFUNGIN ACETATE 2025-02-24
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Respiratory 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 2008-11-26
- Latest
- 2024-12-10
- Applications
- 5